Insulet’s Omnipod 5 System automatically adjusts insulin delivery every five minutes based on blood glucose data from a connected CGM. Image credit: Insulet. Diabetes patients in the US will have ...

More than a year after getting the FDA nod for its CGM FreeStyle Libre 2, Abbott landed FDA clearance for the system’s iOS companion app. This new designation allows FreeStyle Libre 2 users to access ...

t:slim X2 Insulin Pump from Tandem Diabetes Care with Abbott’s Freestyle Libre 2 Plus sensor integration now available in the United States. [Image courtesy of Abbott/Tandem Diabetes Care] Abbott ...

FreeStyle Libre 2 sensors will be phased out in the UK by the end of August 2025, meaning that people living with diabetes who use the sensors will need to transition to using FreeStyle Libre 2 Plus ...

The Omnipod 5 with the Abbott FreeStyle Libre 2 Plus. [Image courtesy of Insulet] Insulet (Nasdaq:PODD) today announced compatibility between its Omnipod 5 insulin pump and the Abbott (NYSE:ABT) ...

Abbott's world's leading1 and affordable2 integrated continuous glucose monitoring (iCGM) sensors are cleared for connectivity with automated insulin delivery (AID) systems in the U.S. Sensors also ...

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced ...

Abbott announced yesterday that its recently cleared FreeStyle Libre 2 integrated continuous glucose monitoring (CGM) system is now covered by the Centers for Medicare and Medicaid Services (CMS), and ...

ACTON, Mass., November 20, 2024--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products ...

Data from Abbott’s REFLECT study show for the first time that the use of its continuous glucose monitoring technology, Freestyle Libre, can help lessen the severity of cardiovascular complications in ...